Navigation Links
Orexigen Therapeutics to Present at the UBS Global Healthcare Conference
Date:5/17/2013

SAN DIEGO, May 17, 2013 /PRNewswire/ -- Orexigen® Therapeutics, Inc. (Nasdaq: OREX) today announced that management will present a company overview at the UBS Global Healthcare Conference in New York. The presentation is scheduled for Wednesday, May 22nd at 11 a.m. Eastern Time. To listen to the live webcast or a replay of the presentation, please visit the Investor Relations section of the Company's Web site at www.orexigen.com. A replay will be available for 14 days after the event.

About Orexigen® Therapeutics
Orexigen Therapeutics, Inc. is a biopharmaceutical company focused on the treatment of obesity. The Company's lead product candidate is Contrave®, which has completed Phase 3 clinical trials and for which a New Drug Application has been submitted and reviewed by the FDA. The Company has also reached agreement with the FDA on a Special Protocol Assessment (SPA) for the Light Study, the Contrave cardiovascular outcomes trial. The Company's other product candidate, Empatic™, has completed Phase 2 clinical trials. Further information about the Company can be found at www.orexigen.com.Orexigen Contact:

Media Contact:  McDavid Stilwell

Denise PowellVP, Corporate Communications and Business Development

BrewLife(858) 875-8629

(510) 703-9491


'/>"/>
SOURCE Orexigen Therapeutics, Inc.
Copyright©2012 PR Newswire.
All rights reserved

Page: 1

Related medicine technology :

1. Unigenes Potent, Anorexigenic Peptide, UGP281, Demonstrates Dramatic Dose Dependent Reductions in Food Intake with Subsequent Significant Body Weight Reduction in Preclinical Studies
2. Orexigen Therapeutics to Present at the Jefferies 2012 Global Healthcare Conference
3. Orexigen Therapeutics to Present at the JMP Securities Healthcare Conference
4. Orexigen Therapeutics Announces the Light Study is Enrolling Faster than Originally Projected
5. Orexigen Therapeutics Schedules August 7, 2012 Webcast Discussion of Financial Results for the Second Quarter Ended June 30, 2012
6. Orexigen Therapeutics Reports Financial Results for the Second Quarter Ended June 30, 2012
7. Orexigen Therapeutics Announces Presentations at Upcoming Investor Conferences
8. Orexigen Therapeutics announces continued rapid enrollment into the Light Study; enrollment now expected to close by year end 2012
9. Orexigen Therapeutics Reports Financial Results for the Third Quarter Ended September 30, 2012
10. Orexigen Therapeutics To Host Analyst Day Event on December 18, 2012
11. Orexigen Therapeutics to Present at Upcoming Investor Conferences
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:10/15/2019)... ... October 15, 2019 , ... Twiggy Bean, Ph.D., wanted to ... in embittered divorce battles make better decisions and become truly child focused. This objective ... bully, be resilient, and STOP the cycle! Don’t be a divorce bully!” (published by ...
(Date:10/11/2019)... ... October 11, 2019 , ... Based on data for the first ... increase in deceased organ donors over 2018. Through August 31, 7,786 deceased donors have ... national database . At this pace, the Association of Organ Procurement Organizations (AOPO) ...
(Date:10/10/2019)... ... October 10, 2019 , ... Hospice of Westchester ... September 26, at the Westchester Country Club in Rye. The event honored Grassy ... organization and its mission. , “In Celebration” featured live entertainment, culinary delights and ...
Breaking Medicine Technology:
(Date:10/8/2019)... West Hartford, CT (PRWEB) , ... October 08, ... ... surgeons at JawFixers in West Hartford, CT, help patients with missing teeth restore ... each year, this team of oral surgeons relies on advanced i-CAT® 3D Cone ...
(Date:10/8/2019)... ... 2019 , ... PotentiaMetrics, an Austin, TX based healthcare data ... Officer. Dr. Henderson will be responsible for the development and management of the ... Chair of both the Informatics Governance and the Inpatient Clinical Informatics Committees at ...
(Date:10/8/2019)... , ... October 08, 2019 , ... ... managers, administrators and pathologists, 4medica® President Gregg Church will inform conference ... first-to-market solution reinventing labs orders management-by starting with the right, clean patient data. ...
(Date:10/8/2019)... ... October 08, 2019 , ... Smile Brands Inc. has been named ... site, Comparably. Smile Brands, a leading dental support organization with nearly 440 affiliated practices ... deliver Smiles for Everyone®. The Happiness Award is the latest in a series ...
(Date:10/8/2019)... ... October 08, 2019 , ... EBSCO Information Services ( EBSCO ... procedures content from Dynamic Health™ into the MCN platform. Dynamic Health ... critical skills. MCN provides custom policy content, document management software and compliance expertise ...
Breaking Medicine News(10 mins):